No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MNMD241220C7000
- 0.11
- -0.07-38.89%
15min DelayClose Dec 20 16:00 ET
0.30High0.10Low
0.15Open0.18Pre Close176 Volume1.19K Open Interest7.00Strike Price2.97KTurnover0.00%IV-0.70%PremiumDec 20, 2024Expiry Date0.16Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma65.09Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Mind Medicine Price Target Announced at $20.00/Share by Chardan Capital
Mind Medicine Initiated at Buy by Chardan Capital
MindMed To Be Added To The Nasdaq Biotechnology Index, Effective At Market Open On December 23, 2024
MindMed to Be Added to the Nasdaq Biotechnology Index
Mind Medicine Analyst Ratings
Oppenheimer Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $20